Enlivex Therapeutics (ENLV) announced the closing of the Company’s previously announced $212,000,000 private investment. Enlivex intends to use net proceeds from private placement to implement the first RAIN prediction markets token treasury strategy, while continuing its focus on the Company’s core business operations.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENLV:
- 3 Penny Stocks to Watch Now, 11/25/25
- Crypto Currents: Upbit plans IPO, Revolut hits $75B valuation
- Enlivex Reports Positive Six-Month Data for Knee Osteoarthritis Trial
- Enlivex Completes Private Placement to Fund Digital Asset Strategy
- Enlivex Therapeutics downgraded to Hold from Buy at D. Boral Capital